TIGIT/PVR/NECTIN immune checkpoint axis expression across breast cancer subtypes.

被引：0
|
作者：
DuPree, Kelly J. [1 ]
Molinero, Luciana [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Expression of the Immune Checkpoint Axis-PVR/TIGIT in Small Cell Lung Cancer
    Yu, H.
    Koczara, C.
    Lohinai, Z.
    Badzio, A.
    Czapiewski, P.
    Dome, B.
    Moldvay, J.
    Fillinger, J.
    Gao, D.
    Ellison, K.
    Ren, S.
    Caldwell, C., Jr.
    Rivard, C.
    Hirsch, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S974 - S975
  • [2] Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
    Stamm, Hauke
    Oliveira-Ferrer, Leticia
    Grossjohann, Eva-Maria
    Muschhammer, Jana
    Thaden, Vanessa
    Brauneck, Franziska
    Kischel, Roman
    Mueller, Volkmar
    Bokemeyer, Carsten
    Fiedler, Walter
    Wellbrock, Jasmin
    ONCOIMMUNOLOGY, 2019, 8 (12):
  • [3] Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancer
    Boissiere-Michot, Florence
    Chateau, Marie-Christine
    Thezenas, Simon
    Guiu, Severine
    Bobrie, Angelique
    Jacot, William
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
    Chiang, Eugene Y.
    Mellman, Ira
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)
  • [5] Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR
    Xiuman Zhou
    Jiangfeng Du
    Hongfei Wang
    Chunxia Chen
    Ling Jiao
    Xiangrui Cheng
    Xiaowen Zhou
    Shaomeng Chen
    Shanshan Gou
    Wenshan Zhao
    Wenjie Zhai
    Junhui Chen
    Yanfeng Gao
    Cell Communication and Signaling, 18
  • [6] Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR
    Zhou, Xiuman
    Du, Jiangfeng
    Wang, Hongfei
    Chen, Chunxia
    Jiao, Ling
    Cheng, Xiangrui
    Zhou, Xiaowen
    Chen, Shaomeng
    Gou, Shanshan
    Zhao, Wenshan
    Zhai, Wenjie
    Chen, Junhui
    Gao, Yanfeng
    CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
  • [7] Characterization of immune microenvironment and heterogeneity in breast cancer subtypes.
    Jain, Drashti
    Liao, Linda
    Hopkins, Megan
    Quintayo, Mary Anne
    Talebian, Vida
    Bayani, Jane
    Cheung, Alison
    Yaffe, Martin
    Bartlett, John
    Spears, Melanie
    CANCER RESEARCH, 2021, 81 (13)
  • [8] Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer
    Hauke Stamm
    Jasmin Wellbrock
    Walter Fiedler
    Mammalian Genome, 2018, 29 : 694 - 702
  • [9] Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer
    Stamm, Hauke
    Wellbrock, Jasmin
    Fiedler, Walter
    MAMMALIAN GENOME, 2018, 29 (11-12) : 694 - 702
  • [10] Expression of the immune checkpoint receptor TIGIT in seminoma
    Lennartz, Maximillian
    Blessin, Niclas C.
    Hinsch, Andrea
    Simon, Ronald
    Kluth, Martina
    Fischer, Kristine
    Hube-Magg, Claudia
    Li, Wenchao
    Mandelkow, Tim
    Debatin, Nicolaus F.
    Hoeflmayer, Doris
    Sauter, Guido
    Izbicki, Jakob R.
    Minner, Sarah
    Buescheck, Franziska
    Uhlig, Ria
    Dum, David
    Krech, Till
    Luebke, Andreas M.
    Wittmer, Corinna
    Jacbosen, Frank
    Burandt, Eike
    Steurer, Stefan
    Wilczak, Waldemar
    CANCER RESEARCH, 2019, 79 (13)
12345